These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37489937)

  • 21. Placental Pathology in Down Syndrome-Associated Transient Abnormal Myelopoiesis.
    Kuo E; Kumarapeli AR
    Arch Pathol Lab Med; 2020 Mar; 144(3):388-393. PubMed ID: 30969155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant progenitors common to megakaryocytic and myeloid cells in a Down's infant with transient abnormal myelopoiesis.
    Sato A; Imaizumi M; Noro T; Ichinohasama R; Saito T; Yoshinari M; Suwabe N; Suzuki H; Koizumi Y; Cui Y
    Leuk Res; 1995 Nov; 19(11):811-5. PubMed ID: 8551797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of Full-Length GATA1 Expression in Megakaryocytes Is a Sensitive and Specific Immunohistochemical Marker for the Diagnosis of Myeloid Proliferative Disorder Related to Down Syndrome.
    Lee WY; Weinberg OK; Evans AG; Pinkus GS
    Am J Clin Pathol; 2018 Mar; 149(4):300-309. PubMed ID: 29481579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome.
    Brink DS
    Adv Anat Pathol; 2006 Sep; 13(5):256-62. PubMed ID: 16998319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient abnormal myelopoiesis in neonates: GATA get the diagnosis.
    Bombery M; Vergilio JA
    Arch Pathol Lab Med; 2014 Oct; 138(10):1302-6. PubMed ID: 25268193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving circulatory disturbance in transient abnormal myelopoiesis.
    Koga H; Miyako K; Suga N; Hidaka T; Takahashi N
    J Pediatr Hematol Oncol; 2012 May; 34(4):e149-51. PubMed ID: 22134612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of megakaryocytic and myeloid markers in blasts of transient abnormal myelopoiesis in a stillbirth with Down syndrome: report of histopathological findings of an autopsy case.
    Ishigaki H; Miyauchi J; Yokoe A; Nakayama M; Yanagi T; Taga T; Ohta S; Itoh Y; Ogasawara K
    Hum Pathol; 2011 Jan; 42(1):141-5. PubMed ID: 20970166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal diagnosis of Down syndrome combined with transient abnormal myelopoiesis in foetuses with a GATA1 gene variant: two case reports.
    Tang H; Hu J; Liu L; Lv L; Lu J; Yang J; Lu J; Chen Z; Yang C; Chen D; Fu J; Wu J
    Mol Cytogenet; 2023 Oct; 16(1):27. PubMed ID: 37858167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features of 35 Down syndrome patients with transient abnormal myelopoiesis at a single institution.
    Yamato G; Park MJ; Sotomatsu M; Kaburagi T; Maruyama K; Kobayashi T; Nishi A; Sameshima K; Ohki K; Hayashi Y
    Int J Hematol; 2021 May; 113(5):662-667. PubMed ID: 33394336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
    Greene ME; Mundschau G; Wechsler J; McDevitt M; Gamis A; Karp J; Gurbuxani S; Arceci R; Crispino JD
    Blood Cells Mol Dis; 2003; 31(3):351-6. PubMed ID: 14636651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling Down Syndrome Myeloid Leukemia by Sequential Introduction of
    Barwe SP; Sebastian A; Sidhu I; Kolb EA; Gopalakrishnapillai A
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blasts in transient leukaemia in neonates with Down syndrome differentiate into basophil/mast-cell and megakaryocyte lineages in vitro in association with down-regulation of truncated form of GATA1.
    Miyauchi J; Ito Y; Tsukamoto K; Takahashi H; Ishikura K; Sugita K; Miyashita T
    Br J Haematol; 2010 Mar; 148(6):898-909. PubMed ID: 20064153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [GATA1-mutation associated leukemia in children with trisomy 21 mosaic].
    Reinhardt D; Reinhardt K; Neuhoff C; Sander A; Klusmann JH; Pekrun A; Sauerbrey A; von Stackelberg A; Rössig C; Creutzig U; Kolenova A
    Klin Padiatr; 2012 Apr; 224(3):153-5. PubMed ID: 22513796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification.
    Matsuo S; Nishinaka-Arai Y; Kazuki Y; Oshimura M; Nakahata T; Niwa A; Saito MK
    PLoS One; 2021; 16(3):e0247595. PubMed ID: 33780474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome.
    Hitzler JK; Cheung J; Li Y; Scherer SW; Zipursky A
    Blood; 2003 Jun; 101(11):4301-4. PubMed ID: 12586620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transient abnormal myelopoiesis in a cytogenetically normal neonate.
    Yanase K; Kato K; Katayama N; Mouri Y; Kobayashi C; Shiono J; Abe M; Yoshimi A; Koike K; Arai J; Tsuchida M
    Int J Hematol; 2010 Oct; 92(3):527-30. PubMed ID: 20859711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and laboratory analysis of a neonate with Down syndrome and a novel GATA1 gene mutation].
    Zheng R; Zhang W; Chen B; Shen Z; Lin A
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Apr; 36(4):322-326. PubMed ID: 30950017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prominent megakaryocytic dysplasia after regression of transient abnormal myelopoiesis associated with GATA-1 mutation.
    Anoop P; Atra A
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):640. PubMed ID: 23007419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two Novel
    Chukua K; Netsawang C; Padungthai K; Khetkham T; Chokevittaya P; Poonjearansilp O; Prachuktum S; Kositamongkol S; Techasatit W; Silapamongkolkul P; Satayasai W; Pusongchai T; Surapolchai P; Rojnueangnit K
    J Pediatr Genet; 2019 Dec; 8(4):187-192. PubMed ID: 31687255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute megakaryoblastic leukemia with acquired trisomy 21 and GATA1 mutations in phenotypically normal children.
    Ono R; Hasegawa D; Hirabayashi S; Kamiya T; Yoshida K; Yonekawa S; Ogawa C; Hosoya R; Toki T; Terui K; Ito E; Manabe A
    Eur J Pediatr; 2015 Apr; 174(4):525-31. PubMed ID: 25266042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.